Fidaxomicin Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with fidaxomicin
P
- Pacerone (amiodarone)
- pacritinib
- Pamine FQ (lactobacillus acidophilus / methscopolamine)
- Paxlovid (nirmatrelvir / ritonavir)
- pazopanib
- PCE Dispertab (erythromycin)
- Pediazole (erythromycin / sulfisoxazole)
- Pemazyre (pemigatinib)
- pemigatinib
- Pepto Diarrhea Control (loperamide)
- pexidartinib
- Phillips Colon Health (bifidobacterium infantis / lactobacillus acidophilus)
- Piqray (alpelisib)
- pirtobrutinib
- ponatinib
- Posicor (mibefradil)
- Pradaxa (dabigatran)
- pralsetinib
- Prepopik (citric acid/magnesium oxide/sodium picosulfate)
- Prevpac (amoxicillin / clarithromycin / lansoprazole)
- Primadophilus Bifidus (bifidobacterium infantis / lactobacillus acidophilus)
- Proben-C (colchicine / probenecid)
- Probenecid and Colchicine (colchicine / probenecid)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Procardia (nifedipine)
- Procardia XL (nifedipine)
- Prochieve (progesterone)
- Prodigen (bifidobacterium infantis / lactobacillus acidophilus)
- Progest (progesterone)
- progesterone
- Prograf (tacrolimus)
- Prometrium (progesterone)
- propafenone
- Provella (bifidobacterium infantis / lactobacillus acidophilus)
- prucalopride
- Pyrukynd (mitapivat)
More about fidaxomicin
- fidaxomicin consumer information
- Check interactions
- Compare alternatives
- Reviews (19)
- Side effects
- Dosage information
- During pregnancy
- Drug class: macrolides
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.